Shares of Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) traded down 26.6% during mid-day trading on Friday . The company traded as low as $1.12 and last traded at $1.12. 99 shares changed hands during trading, a decline of 95% from the average session volume of 2,067 shares. The stock had previously closed at $1.5250.
Nutriband Stock Down 26.6%
The business has a 50 day moving average price of $1.30 and a two-hundred day moving average price of $1.48.
Hedge Funds Weigh In On Nutriband
A hedge fund recently bought a new stake in Nutriband stock. Empery Asset Management LP bought a new position in Nutriband Inc. (NASDAQ:NTRBW – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises 0.1% of Empery Asset Management LP’s holdings, making the stock its 20th largest holding.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
Featured Stories
- Five stocks we like better than Nutriband
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
